Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Longitudinal Cohort Registry of Patients Treated With Loncastuximab Tesirine

NCT05160064 is registered in ClinicalTrials.gov with ADC Therapeutics S.A. as lead sponsor.

NCT NCT05160064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05160064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Longitudinal Cohort Registry of Patients Treated With Loncastuximab Tesirine
Lead sponsor
ADC Therapeutics S.A.
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2022
Completion date
January 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphomas